-
Lixisenatide
-
BD01077738320367-13-399+%
-
￥526.05mg
-
Exendin-4
-
BD689155141758-74-997%
-
￥323.010mg
-
(S)-3-(4-(1-((4'-(tert-Butyl)-2,6-dimethyl-[1,1'-biphenyl]-4-yl)oxy)-4,4,4-trifluorobutyl)benzamido)propanoic acid
-
BD6292661488363-78-598%
-
￥840.05mg
-
Semaglutide
-
BD00800278910463-68-299%
-
￥1988.010mg
-
GLP-1(7-36) xAcetate
-
BD011403251119517-19-998%
-
￥890.01mg
-
(S)-2-((4-(6-((4-Cyano-2-fluorobenzyl)oxy)pyridin-2-yl)piperidin-1-yl)methyl)-1-(oxetan-2-ylmethyl)-1H-benzo[d]imidazole-6-carboxylic acid
-
BD010937772230198-02-298%
-
￥2470.050mg
-
Exendin (9-39)
-
BD114767133514-43-999%
-
￥4535.05mg
-
Liraglutide
-
BD136402204656-20-298%
-
￥715.010mg
-
3-(4-((1-(trans-4-(tert-Butyl)cyclohexyl)-3-(4-(trifluoromethoxy)phenyl)ureido)methyl)benzamido)propanoic acid
-
BD764622307983-31-998%
-
￥463.02mg
-
4-(3-(Benzyloxy)phenyl)-2-(ethylsulfinyl)-6-(trifluoromethyl)pyrimidine
-
BD7655851371569-69-597%
-
￥1871.0100mg
-
3,5-Bis(4-nitrobenzylidene)tetrahydro-4H-thiopyran-4-one 1,1-dioxide
-
BD159874108477-18-597%
-
￥1055.0100mg
-
(5S,11S,14S,17S,20S,23S,26S,29S,32S,35S,38S,41S,44S,50S,53S,56S,59S,62S,65S,68S,71S,74S,77S,80S,86S)-20-((1H-Indol-3-yl)methyl)-86-((S)-2-((S)-2-amino-3-(1H-imidazol-5-yl)propanamido)propanamido)-44-(3-amino-3-oxopropyl)-11,35-bis(4-aminobutyl)-29,77-dibenzyl-26-((S)-sec-butyl)-32,50-bis(2-carboxyethyl)-68-(carboxymethyl)-5-(3-guanidinopropyl)-56-(4-hydroxybenzyl)-74,80-bis((R)-1-hydroxyethyl)-59,62,71-tris(hydroxymethyl)-17,53-diisobutyl-14,65-diisopropyl-23,38,41-trimethyl-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55,58,61,64,67,70,73,76,79,82,85-octacosaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54,57,60,63,66,69,72,75,78,81,84-octacosaazanonaoctacontanedioic acid
-
BD764625106612-94-698%
-
￥816.010mg
-
2-((4-((S)-2-(5-Chloropyridin-2-yl)-2-methylbenzo[d][1,3]dioxol-4-yl)piperidin-1-yl)methyl)-1-(((S)-oxetan-2-yl)methyl)-1H-benzo[d]imidazole-6-carboxylic acid
-
BD015817252401892-75-795%
-
￥883.010mg
-
Teduglutide
-
BD01173691197922-42-298%
-
￥1617.01mg
-
4-((1-(4-Cyclohexylphenyl)-3-(3-(methylsulfonyl)phenyl)ureido)methyl)-N-(1H-tetrazol-5-yl)benzamide
-
BD01104870307986-98-798%
-
￥4532.050mg
-
LY3437943
-
BD015674462381089-83-298+%
-
￥909.050mg
-
Human glucagon
-
BD13209316941-32-599%
-
￥1068.050mg
-
3-((1S,2S)-1-(5-((S)-2,2-Dimethyltetrahydro-2H-pyran-4-yl)-2-((S)-3-(3-(4-fluoro-1-methyl-1H-indazol-5-yl)-2-oxo-2,3-dihydro-1H-imidazol-1-yl)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine-5-carbonyl)-1H-indol-1-yl
-
BD011246282212020-52-398%
-
￥396.010mg
-
Methyl (1S,4aS,5R,7S,7aS)-5,7-dihydroxy-7-methyl-1-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate
-
BD15108364421-28-997%
-
￥880.025mg
-
7-37-Glucagon-like peptide I (human) Acetate(1:x)
-
BD011218731450806-98-098%
-
￥
